Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Aug;26(2):277–279. doi: 10.1128/aac.26.2.277

In vitro activity of HR 810, a new cephalosporin.

M A Bertram, D A Bruckner, L S Young
PMCID: PMC284139  PMID: 6593000

Abstract

The in vitro susceptibility of 409 clinical isolates to HR 810, a new cephalosporin, was evaluated and compared with their susceptibility to aztreonam, cefazolin, ceftazidime, imipenem, moxalactam, piperacillin, and gentamicin. On a weight basis, the activity of HR 810 against gram-negative bacilli was equivalent or superior to that of the other beta-lactam agents except imipenem.

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauernfeind A. Susceptibility of gram-positive aerobic cocci to the new cephalosporin HR 810. Eur J Clin Microbiol. 1983 Aug;2(4):354–355. doi: 10.1007/BF02019468. [DOI] [PubMed] [Google Scholar]
  2. Cullmann W., Opferkuch W., Stieglitz M. Relation between beta-lactamase production and antimicrobial activity: comparison of the new compound HR 810 with cefotaxime. Eur J Clin Microbiol. 1983 Aug;2(4):350–352. doi: 10.1007/BF02019466. [DOI] [PubMed] [Google Scholar]
  3. Cullmann W., Opferkuch W., Stieglitz M., Werkmeister U. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives. Antimicrob Agents Chemother. 1982 Aug;22(2):302–307. doi: 10.1128/aac.22.2.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kurtz T. O., Winston D. J., Hindler J. A., Young L. S., Hewitt W. L., Martin W. J. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother. 1980 Oct;18(4):645–648. doi: 10.1128/aac.18.4.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lea A. S., Sudan A. W., Wood B. A., Gentry L. O. Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults. Antimicrob Agents Chemother. 1982 Jul;22(1):32–35. doi: 10.1128/aac.22.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Machka K., Braveny I. In vitro activity of HR 810, a new broad-spectrum cephalosporin. Eur J Clin Microbiol. 1983 Aug;2(4):345–349. doi: 10.1007/BF02019465. [DOI] [PubMed] [Google Scholar]
  7. Neu H. C. The new beta-lactamase-stable cephalosporins. Ann Intern Med. 1982 Sep;97(3):408–419. doi: 10.7326/0003-4819-97-3-408. [DOI] [PubMed] [Google Scholar]
  8. Pakter R. L., Russell T. R., Mielke C. H., West D. Coagulopathy associated with the use of moxalactam. JAMA. 1982 Sep 3;248(9):1100–1100. [PubMed] [Google Scholar]
  9. Platt R., Ehrlich S. L., Afarian J., O'Brien T. F., Pennington J. E., Kass E. H. Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrob Agents Chemother. 1981 Sep;20(3):351–355. doi: 10.1128/aac.20.3.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Preheim L. C., Penn R. G., Sanders C. C., Goering R. V., Giger D. K. Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections. Antimicrob Agents Chemother. 1982 Dec;22(6):1037–1041. doi: 10.1128/aac.22.6.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Seibert G., Klesel N., Limbert M., Schrinner E., Seeger K., Winkler I., Lattrell R., Blumbach J., Dürckheimer W., Fleischmann K. HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum. Arzneimittelforschung. 1983;33(8):1084–1086. doi: 10.1002/chin.198350201. [DOI] [PubMed] [Google Scholar]
  12. Seibert G., Limbert M., Winkler I., Dick T. The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides. Infection. 1983 Sep-Oct;11(5):275–279. doi: 10.1007/BF01641262. [DOI] [PubMed] [Google Scholar]
  13. Tolxdorff-Neutzling R. M., Wiedemann B. HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase. Eur J Clin Microbiol. 1983 Aug;2(4):352–354. doi: 10.1007/BF02019467. [DOI] [PubMed] [Google Scholar]
  14. Weitekamp M. R., Aber R. C. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA. 1983 Jan 7;249(1):69–71. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES